News

Filter

Current filters:

None

7920 to 7929 of 96144 results

Lundbeck buys remaining rights to desmoteplase from Paion

29-02-2012

Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Bayer and J&J’s Xarelto gets US Priority Review for new indication

29-02-2012

The US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Frontage and Fanghui Pharma launch $10 million collaboration

28-02-2012

Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Vernalis is "worth the wait," according to Edison

28-02-2012

The proposed £65.9 million ($104 million) equity raise (net of costs) by UK biotech firm Vernalis…

BiotechnologyFinancialLicensingVernalis

Slower growth in Swiss economy will impact pharma, says BMI

28-02-2012

It is the view that the Swiss economy will record slower growth in 2012, says Business Monitor International…

EuropeMarkets & MarketingPharmaceutical

Merck warned for not carrying out post-approval sitagliptin study

28-02-2012

The US Food and Drug Administration (FDA) has sent a warning letter to Merck & Co for failing to carry…

DiabetesJanumetJanuviaMerck & CoPharmaceuticalRegulationsitagliptinSitagliptin Metformin HCL

Roche extends Illumina takeover deadline

28-02-2012

Roche has extended its $5.7 billion hostile takeover offer for genetic sequencing specialist Illumina…

HomeIlluminaMergers & AcquisitionsPharmaceuticalRoche

GSK inks $300m rare diseases alliance with Angiochem

28-02-2012

GlaxoSmithKline has forged an R&D alliance with Montreal, Canada-based Angiochem that will focus on the…

AngiochemCerezymeGenzymeGSKNeurologicalPharmaceuticalRare diseasesShireVpriv

New data support efficacy of Astellas' mirabegron for overactive bladder

28-02-2012

Astellas Pharma has reported the results of three separate clinical trials which further support the…

Astellas PharmaBetanisGenito-urinaryHomemirabegronPharmaceuticalVESIcare

7920 to 7929 of 96144 results

Back to top